Tg(tetO-Mcpt1)1Mrab
Transgene Detail
|
|
| Symbol: |
Tg(tetO-Mcpt1)1Mrab |
| Name: |
transgene insertion 1, Marlene Rabinovitch |
| MGI ID: |
MGI:3772577 |
| Synonyms: |
RVCH+, TRE-RVCH-HA |
| Transgene: |
Tg(tetO-Mcpt1)1Mrab Location: unknown
|
| Alliance: |
Tg(tetO-Mcpt1)1Mrab page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence) |
| Inducer: |
|
doxycycline/tetracycline |
| Mutation: |
|
Insertion
|
| |
|
Tg(tetO-Mcpt1)1Mrab expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Note |
| rat |
Vch (29265) |
|
|
| |
|
Mutation details: The transgene was designed with the tetracycline-responsive element (TRE; also called tet-operator or tetO) upstream of a rat vascular chymase (RVCH or Mcpt1) gene modified such that a human influenza hemagglutinin (HA) tag is added to the C terminus of mature RVCH protein. With the addition of dox expression of the RVCH-HA fusion protein can be completely abolished, reversing the hypertension phenotype.
(J:70031)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:70031 Ju H, et al., Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7469-74 |
| All: |
1 reference(s) |
|